REZERA ANNOUNCES POSITIVE RESOLVE-2 PHASE 2 CLINICAL TRIAL RESULTS DEMONSTRATING FAVORABLE SAFETY AND TOLERABILITY PROFILE FOR RUVONOFLAST IN COMBINATION WITH SEMAGLUTIDE

Reuters · 5d ago

Please log in to view news